NASDAQ · CPIX
Cumberland Pharmaceuticals Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CPIX: Nov 3, 2026
Cumberland Pharmaceuticals Inc. Common Stock is estimated to report earnings on 11/03/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.06.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · RTTNews · Fintel · BNK Invest- MarketBeat · Oct 26, 6:02 PM EDTCumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne CardiomyopathyCumberland Pharmaceuticals (NASDAQ:CPIX) said it plans to begin a rolling New Drug Application submission for Dyscorban, its ifetroban candidate for cardiomyopathy associated with Duchenne muscular dystrophy, after the U.S. Food and Drug Administration granted the company’s reque
- RTTNews · Oct 23, 10:28 PM EDTCumberland Pharma Reports Phase 2a Safety Data For Ifetroban In Systemic Sclerosis; Shares Slide(RTTNews) – Cumberland Pharmaceuticals Inc. (CPIX) reported results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban in patients with systemic sclerosis (SSc), with the study supporting the drug's safety and tolerability in this rare autoimmune disease.
- Fintel · Oct 23, 7:58 PM EDTCumberland Pharmaceuticals Inc. Announces Top-Line Results from Phase 2a ASSIST-SSc TrialOn October 23, 2026, Cumberland Pharmaceuticals Inc. announced top-line results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban for patients with systemic sclerosis. These results support the safety and tolerability of ifetroban in this rare disease population.View t
- BNK Invest · Oct 20, 12:24 PM EDTTuesday Sector Leaders: Biotechnology, DrugsIn trading on Tuesday, biotechnology shares were relative leaders, up on the day by about 4.2%. Leading the group were shares of Myriad Genetics, up about 37.5% and shares of Larimar Therapeutics up about 14.4% on the day. Also showing relative strength are drugs shares, up on
- RTTNews · Aug 26, 4:33 AM EDTBiotech Stocks At 52-Week Highs – GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%(RTTNews) – The following biotech stocks reached a 52-week high on August 25, 2026, driven by key catalysts including positive clinical trial results or the issuance of quarterly reports.
- RTTNews · Aug 11, 4:05 AM EDTBiotech Stocks At 52-Week Highs – SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX(RTTNews) – The following biotech stocks reached a 52-week high on August 10, 2026, driven by key catalysts such as positive quarterly reports or the release of promising results from clinical trials.
- MarketBeat · Aug 4, 7:04 PM EDTCumberland Pharmaceuticals Q2 Earnings Call HighlightsCumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an innovation-focused biopharmaceutical business following the sale of its branded U.S. com
- RTTNews · Aug 3, 10:31 PM EDTTop Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentum(RTTNews) – Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and Autolus Therapeutics, following the releas
- Zacks · Jul 31, 2:08 AM EDTPossible Generic Drug Tariffs and 2 MicrocapsGeneric drug tariffs could impact ELTP and CPIX.
- RTTNews · Jul 16, 4:19 AM EDTBiotech Stocks At 52-Week Highs – CPIX, MRVI, ANGO, ACHC, TDOC(RTTNews) – The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.
- Zacks · Jul 15, 11:22 AM EDTELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.
- Zacks · Jun 4, 9:04 AM EDTCumberland's Ifetroban Shows Potential to Limit MetastasisCPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promising early signs of reducing cancer metastasis in high-risk patients.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Cumberland Pharmaceuticals Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.